139 related articles for article (PubMed ID: 21446207)
21. Anti-cyclic citrullinated peptide antibodies distinguish hepatitis B virus (HBV)-associated arthropathy from concomitant rheumatoid arthritis in patients with chronic HBV infection.
Lim MK; Sheen DH; Lee YJ; Mun YR; Park M; Shim SC
J Rheumatol; 2009 Apr; 36(4):712-6. PubMed ID: 19286846
[TBL] [Abstract][Full Text] [Related]
22. Antibodies against cyclic citrullinated peptide and IgA rheumatoid factor predict the development of rheumatoid arthritis.
Rantapää-Dahlqvist S; de Jong BA; Berglin E; Hallmans G; Wadell G; Stenlund H; Sundin U; van Venrooij WJ
Arthritis Rheum; 2003 Oct; 48(10):2741-9. PubMed ID: 14558078
[TBL] [Abstract][Full Text] [Related]
23. Value of anti-modified citrullinated vimentin and third-generation anti-cyclic citrullinated peptide compared with second-generation anti-cyclic citrullinated peptide and rheumatoid factor in predicting disease outcome in undifferentiated arthritis and rheumatoid arthritis.
van der Linden MP; van der Woude D; Ioan-Facsinay A; Levarht EW; Stoeken-Rijsbergen G; Huizinga TW; Toes RE; van der Helm-van Mil AH
Arthritis Rheum; 2009 Aug; 60(8):2232-41. PubMed ID: 19644872
[TBL] [Abstract][Full Text] [Related]
24. The role of anti-mutated citrullinated vimentin antibodies in the diagnosis of early rheumatoid arthritis.
Liu X; Jia R; Zhao J; Li Z
J Rheumatol; 2009 Jun; 36(6):1136-42. PubMed ID: 19447936
[TBL] [Abstract][Full Text] [Related]
25. [Topics on immunological tests for rheumatoid arthritis].
Kumagai S; Nishimura K; Hayashi N
Rinsho Byori; 2004 Oct; 52(10):836-43. PubMed ID: 15624500
[TBL] [Abstract][Full Text] [Related]
26. Novel autoantibody markers for early and seronegative rheumatoid arthritis.
Somers K; Geusens P; Elewaut D; De Keyser F; Rummens JL; Coenen M; Blom M; Stinissen P; Somers V
J Autoimmun; 2011 Feb; 36(1):33-46. PubMed ID: 21071175
[TBL] [Abstract][Full Text] [Related]
27. [Comparative characteristics of specific autoantibodies in rheumatoid arthritis].
Lapin SV; Maslianskiĭ AL; Mazurov VI; Totolian AA
Ter Arkh; 2005; 77(12):53-9. PubMed ID: 16514821
[TBL] [Abstract][Full Text] [Related]
28. Cytokines, autoantibodies and viral antibodies in premorbid and postdiagnostic sera from patients with rheumatoid arthritis: case-control study nested in a cohort of Norwegian blood donors.
Jørgensen KT; Wiik A; Pedersen M; Hedegaard CJ; Vestergaard BF; Gislefoss RE; Kvien TK; Wohlfahrt J; Bendtzen K; Frisch M
Ann Rheum Dis; 2008 Jun; 67(6):860-6. PubMed ID: 17644543
[TBL] [Abstract][Full Text] [Related]
29. [New biomarkers for rheumatoid arthritis].
Hayashi N; Nishimura K; Kumagai S
Rinsho Byori; 2008 Apr; 56(4):297-308. PubMed ID: 18516964
[TBL] [Abstract][Full Text] [Related]
30. Diagnostic value of anti-cyclic citrullinated Peptide antibody in patients with rheumatoid arthritis.
Zeng X; Ai M; Tian X; Gan X; Shi Y; Song Q; Tang F
J Rheumatol; 2003 Jul; 30(7):1451-5. PubMed ID: 12858440
[TBL] [Abstract][Full Text] [Related]
31. Second generation anti-cyclic citrullinated peptide (anti-CCP2) antibodies can replace other anti-filaggrin antibodies and improve rheumatoid arthritis diagnosis.
Grootenboer-Mignot S; Nicaise-Roland P; Delaunay C; Meyer O; Chollet-Martin S; Labarre C
Scand J Rheumatol; 2004; 33(4):218-20. PubMed ID: 15370715
[TBL] [Abstract][Full Text] [Related]
32. Role of anticyclic citrullinated peptide in the diagnosis of early rheumatoid factor-negative suspected rheumatoid arthritis: is it worthwhile to order the test?
Panchagnula R; Rajiv SR; Prakash J; Chandrashekara S; Suresh KP
J Clin Rheumatol; 2006 Aug; 12(4):172-5. PubMed ID: 16891919
[TBL] [Abstract][Full Text] [Related]
33. [Comparison and relevance of rheumatoid factors, antikeratin antibodies and anti-cyclic citrullinated peptides antibodies in rheumatoid arthritis].
Galati S; Beauvillain C; Renier G; Jeannin P; Masson C; Chevailler A
Ann Biol Clin (Paris); 2008; 66(2):157-64. PubMed ID: 18390426
[TBL] [Abstract][Full Text] [Related]
34. [Early prediction of joint destruction in rheumatoid arthritis].
Eguchi K
Clin Calcium; 2007 Apr; 17(4):517-25. PubMed ID: 17404480
[TBL] [Abstract][Full Text] [Related]
35. Contribution of PTPN22 1858T, TNFRII 196R and HLA-shared epitope alleles with rheumatoid factor and anti-citrullinated protein antibodies to very early rheumatoid arthritis diagnosis.
Goëb V; Dieudé P; Daveau R; Thomas-L'otellier M; Jouen F; Hau F; Boumier P; Tron F; Gilbert D; Fardellone P; Cornélis F; Le Loët X; Vittecoq O
Rheumatology (Oxford); 2008 Aug; 47(8):1208-12. PubMed ID: 18535030
[TBL] [Abstract][Full Text] [Related]
36. The HLA-DRB1 shared epitope is not associated with antibodies against cyclic citrullinated peptide in Chinese patients with rheumatoid arthritis.
Xue Y; Zhang J; Chen YM; Guan M; Zheng SG; Zou HJ
Scand J Rheumatol; 2008; 37(3):183-7. PubMed ID: 18465452
[TBL] [Abstract][Full Text] [Related]
37. [Diagnostic performance of anti-cyclic citrullinated antibodies and IgM rheumatoid factor in rheumatoid arthritis].
Lemos A; Ramos MP; Furtado MJ; Carvalho C; Santos MJ; Silva JC; Ventura H
Acta Reumatol Port; 2007; 32(4):345-9. PubMed ID: 18159201
[TBL] [Abstract][Full Text] [Related]
38. [Immunologic laboratory testing in clinical practice for rheumatoid arthritis].
Ota T
Rinsho Byori; 2006 Aug; 54(8):861-8. PubMed ID: 16989407
[TBL] [Abstract][Full Text] [Related]
39. Easy and accurate diagnosis of rheumatoid arthritis using anti-cyclic citrullinated peptide 2 antibody, swollen joint count, and C-reactive protein/rheumatoid factor.
Yamane T; Hashiramoto A; Tanaka Y; Tsumiyama K; Miura Y; Shiozawa K; Chihara K; Shiozawa S
J Rheumatol; 2008 Mar; 35(3):414-20. PubMed ID: 18203327
[TBL] [Abstract][Full Text] [Related]
40. A new strategy for the early diagnosis of rheumatoid arthritis: a combined approach.
Tedesco A; D'Agostino D; Soriente I; Amato P; Piccoli R; Sabatini P
Autoimmun Rev; 2009 Jan; 8(3):233-7. PubMed ID: 18708166
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]